[{“box”:0,”content”:”
n
n
- n t
n
Sakshi Chaudhary, Samiksha Bhor
[/foreach]
n
n
n
- [foreach 286] [if 1175 not_equal=””]n t
- Student, Bioinformatics Associate, University Institute of Biotechnology, Chandigarh University, Department of Biotechnology, Bionome, Punjab, Karnataka, India, India
n[/if 1175][/foreach]
n
Abstract
nObjective : The of this research is to evaluate the feasibility of using molecular docking techniques to identify novel acetylcholinesterase, a key enzyme implicated in the pathogenesis of Alzheimer’s disease, a neurodegenerative disorder with a gradual but steady progression to death, due to the gradual accumulation of beta-plaques and neurofibrillary tangles, as well as a decline in acetylcholine levels. Due to its function in converting acetylcholine into acyl and choline molecules, acetylcholinesterase is an enzyme that could potentially be the target of future Alzheimer’s disease treatments. Methods: In the current research, findings of an in-silico study were examined or developing a novel remedy to combat AD. IMPPAT database was employed to retrieve the phytocompounds from Salix alba. Then the chosen molecules were screened on SwissADME for drug-likeness. Pyrx software was used for the final screening, which revealed the binding affinity between the ligands and the 1b41 target protein. 3d and 2d interactions were examined using Biovia and ligplus respectively. Results: Potential drug candidates for blocking the acetylcholinesterase enzyme include amentoflavone, astragalin, fragile, and salidroside. Conclusion: According to Lipinski’s parameters, none of the compounds are violated (amentoflavone, astragalin, fragile, and salidroside), rendering them all suitable for inhibition activities against the AChE enzyme in AD.
n
Keywords: Salix alba, Alzheimer’s disease, Acetylcholine, Acetylcholinesterase, Molecular docking, ADME analysis, Lipinski rule of 5
n[if 424 equals=”Regular Issue”][This article belongs to International Journal of Genetic Modifications and Recombinations(ijgmr)]
n
n
n
n
n
nn
nn
Full Text
n[if 992 equals=”Open Access”] https://storage.googleapis.com/journals-stmjournals-com-wp-media-to-gcp-offload/2023/10/17d52bdd-7-19-drugs-for-alzheimers-disease-from-salix-alba-discovered-computationally-2.pdf[else] nvar fieldValue = “[user_role]”;nif (fieldValue == ‘indexingbodies’) {n document.write(‘https://storage.googleapis.com/journals-stmjournals-com-wp-media-to-gcp-offload/2023/10/17d52bdd-7-19-drugs-for-alzheimers-disease-from-salix-alba-discovered-computationally-2.pdf’);n }nelse if (fieldValue == ‘administrator’) { document.write(‘https://storage.googleapis.com/journals-stmjournals-com-wp-media-to-gcp-offload/2023/10/17d52bdd-7-19-drugs-for-alzheimers-disease-from-salix-alba-discovered-computationally-2.pdf’); }nelse if (fieldValue == ‘ijgmr’) { document.write(‘https://storage.googleapis.com/journals-stmjournals-com-wp-media-to-gcp-offload/2023/10/17d52bdd-7-19-drugs-for-alzheimers-disease-from-salix-alba-discovered-computationally-2.pdf’); }n else { document.write(‘ ‘); }n [/if 992] [if 379 not_equal=””]n
Browse Figures
n
n[/if 379]n
References
n[if 1104 equals=””]n
- Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021). Alzheimer disease. Nature reviews. Disease primers, 7(1), 33. https://doi.org/10.1038/s41572-021-00269-y
- Tarawneh, R., & Holtzman, D. M. (2012). The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harbor perspectives in medicine, 2(5), a006148. https://doi.org/10.1101/cshperspect.a006148
- Katzman, R., & Saitoh, T. (1991). Advances in Alzheimer’s disease. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 5(3), 278–286.
- Apostolova, L. G., Green, A. E., Babakchanian, S., Hwang, K. S., Chou, Y. Y., Toga, A. W., & Thompson, P. M. (2012). Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease. Alzheimer disease and associated disorders, 26(1), 17–27. https://doi.org/10.1097/WAD.0b013e3182163b62
- 2012 Alzheimer’s disease facts and figures. (2012). Alzheimer’s & Dementia, 8(2), 131–168. https://doi.org/10.1016/j.jalz.2012.02.001
- Breijyeh, Z., & Karaman, R. (2020). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules (Basel, Switzerland), 25(24), 5789. https://doi.org/10.3390/molecules25245789
- Wainaina, M. N., Chen, Z., & Zhong, C. (2014). Environmental factors in the development and progression of late-onset Alzheimer’s disease. Neuroscience bulletin, 30(2), 253–270. https://doi.org/10.1007/s12264-013-1425-9
- Ma, C., Hong, F., & Yang, S. (2022). Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions. Molecules (Basel, Switzerland), 27(4), 1210. https://doi.org/10.3390/molecules27041210
- Jack, C. R., Jr, Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., Sperling, R., … Contributors (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 14(4), 535–562. https://doi.org/10.1016/j.jalz.2018.02.018
- Ellison, J. (2021, July 6). Tau Protein and Alzheimer’s Disease: What’s the Connection? | BrightFocus Foundation. Www.brightfocus.org. https://www.brightfocus.org/alzheimers/
article/tau-protein-and-alzheimers-disease-whats-connection - Soeda, Y., & Takashima, A. (2020). New Insights Into Drug Discovery Targeting Tau Protein. Frontiers in Molecular Neuroscience, 13. https://doi.org/10.3389/fnmol.2020.590896
- Smith, Yolanda. (2019, February 26). Alzheimer’s tangles and plaques: what’s the difference?. News-Medical. Retrieved on April 01, 2023 from https://www.news-medical.net/health/Alzheimers-tangles-and-plaques-whats-the-difference.aspx.
- Stanciu, G. D., Luca, A., Rusu, R. N., Bild, V., Beschea Chiriac, S. I., Solcan, C., Bild, W., & Ababei, D. C. (2019). Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement. Biomolecules, 10(1), 40. https://doi.org/10.3390/biom10010040
- Purves D, Augustine GJ, Fitzpatrick D, et al., editors. Neuroscience. 2nd edition. Sunderland (MA): Sinauer Associates; 2001. Acetylcholine. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11143
- Bekdash R. A. (2021). The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease. International journal of molecular sciences, 22(3), 1273. https://doi.org/10.3390/ijms22031273
- Tripathi, A., & Srivastava, U. (2008). Acetylcholinesterase: A Versatile Enzyme of Nervous System. Annals of Neurosciences, 15(4), 106–111. https://doi.org/10.5214/ans.0972.7531.2008.150403
- Bank, R. P. D. (n.d.). RCSB PDB – 1B41: HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, GLYCOSYLATED PROTEIN. Www.rcsb.org. https://www.rcsb.org/structure/1B41
- Systèmes, D. (2020, March 20). Free Download: BIOVIA Discovery Studio Visualizer. Dassault Systèmes. https://discover.3ds.com/discovery-studio-visualizer-download
- PDBsum home page. (n.d.). Www.ebi.ac.uk. http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/
- PROCHECK home page. (n.d.). Www.ebi.ac.uk. https://www.ebi.ac.uk/thornton-srv/software/PROCHECK/
- asamal @imsc.res.in), A. S. (n.d.). IMPPAT | IMPPAT: Indian Medicinal Plants, Phytochemistry And Therapeutics. Cb.imsc.res.in. Retrieved April 1, 2023, from https://cb.imsc.res.in/imppat/phytochemical/Salix%20alba
- (2022). The PubChem Project. Nih.gov; National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/
- SwissADME. (2017). Swissadme.ch. http://www.swissadme.ch/
- Welcome to the PyRx Website. (n.d.). Pyrx.sourceforge.io. https://pyrx.sourceforge.io/
- LigPlot+ academic licence. (n.d.). Www.ebi.ac.uk. Retrieved April 1, 2023, from https://www.ebi.ac.uk/thornton-srv/software/LigPlus/applicence.html
- Maistro, E. L., Terrazzas, P. M., Perazzo, F. F., Gaivão, I. O. M., Sawaya, A. C. H. F., & Rosa, P. C. P. (2019). Salix alba (white willow) medicinal plant presents genotoxic effects in human cultured leukocytes. Journal of toxicology and environmental health. Part A, 82(23-24), 1223–1234. https://doi.org/10.1080/15287394.2019.1711476
- Alzheimer’s Association. (2019). Milestones. Alzheimer’s Disease and Dementia. https://www.alz.org/alzheimers-dementia/research_progress/milestones
- Shara, M., & Stohs, S. J. (2015). Efficacy and Safety of White Willow Bark (Salix alba) Extracts. Phytotherapy research: PTR, 29(8), 1112–1116. https://doi.org/10.1002/ptr.5377
nn[/if 1104][if 1104 not_equal=””]n
- [foreach 1102]n t
- [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]
n[/foreach]
n[/if 1104]
nn
nn[if 1114 equals=”Yes”]n
n[/if 1114]
n
n
n
International Journal of Genetic Modifications and Recombinations
n
n
n
n
n
n
| Volume | 01 |
| Issue | 02 |
| Received | May 10, 2023 |
| Accepted | July 25, 2023 |
| Published | August 20, 2023 |
n
n
n
n
n[/foreach]
n[/if 1190] [if 1177 not_equal=””]n
n
n[/foreach]
n[/if 1177]
n
n
n
n function myFunction2() {n var x = document.getElementById(“browsefigure”);n if (x.style.display === “block”) {n x.style.display = “none”;n }n else { x.style.display = “Block”; }n }n document.querySelector(“.prevBtn”).addEventListener(“click”, () => {n changeSlides(-1);n });n document.querySelector(“.nextBtn”).addEventListener(“click”, () => {n changeSlides(1);n });n var slideIndex = 1;n showSlides(slideIndex);n function changeSlides(n) {n showSlides((slideIndex += n));n }n function currentSlide(n) {n showSlides((slideIndex = n));n }n function showSlides(n) {n var i;n var slides = document.getElementsByClassName(“Slide”);n var dots = document.getElementsByClassName(“Navdot”);n if (n > slides.length) { slideIndex = 1; }n if (n (item.style.display = “none”));n Array.from(dots).forEach(n item => (item.className = item.className.replace(” selected”, “”))n );n slides[slideIndex – 1].style.display = “block”;n dots[slideIndex – 1].className += ” selected”;n }n n function myfun() {n x = document.getElementById(“editor”);n y = document.getElementById(“down”);n z = document.getElementById(“up”);n if (x.style.display == “none”) {n x.style.display = “block”;n }n else {n x.style.display = “none”;n }n if (y.style.display == “none”) {n y.style.display = “block”;n }n else {n y.style.display = “none”;n }n if (z.style.display == “none”) {n z.style.display = “block”;n }n else {n z.style.display = “none”;n }n }n function myfun2() {n x = document.getElementById(“reviewer”);n y = document.getElementById(“down2”);n z = document.getElementById(“up2”);n if (x.style.display == “none”) {n x.style.display = “block”;n }n else {n x.style.display = “none”;n }n if (y.style.display == “none”) {n y.style.display = “block”;n }n else {n y.style.display = “none”;n }n if (z.style.display == “none”) {n z.style.display = “block”;n }n else {n z.style.display = “none”;n }n }n”}]